Insiders BerGenBio ASA

Equities

BGBIO

NO0010650013

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-29 am EDT			5-day change	1st Jan Change
0.1486 ^NOK	-1.20%		-9.06%	-46.55%

Mar. 20	Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation	CI
Feb. 14	BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs Group Names Nigel McCracken Operating Chief.	23-09-01	MT
BerGenBio ASA Announces Resignation of Francois Thomas from the Board of Directors	23-05-22	CI
BerGenBio ASA Announces Board Appointments	23-02-02	CI
Norway's BerGenBio Names Chief Medical Officer	22-04-11	MT
BerGenBio ASA Appoints Cristina Oliva as Chief Medical Officer, Effective April 25, 2022	22-04-11	CI
BerGenBio Names Former Bristol-Myers Squibb Executive As New Chair	22-01-06	MT
BerGenBio ASA Announces Change of Chairman of Board	22-01-06	CI
BerGenBio : Appoints AcouSort Chairman As CEO	21-08-24	MT
BerGenBio ASA Announces Management Changes	21-08-23	CI
Bergenbio : CEO Steps Down, Successor Named	21-08-23	MT
Bergenbio Announces Executive Changes	21-08-06	CI
BerGenBio ASA Elects Hans Peter Bohn as Member to the Board of Directors	19-03-13	CI
Stein Holst Annexstad´s Expresses Not to Seek Re-Election as Chairman of BerGenBio ASA	19-02-20	CI
BerGenBio ASA Announces Executive Changes	18-11-21	CI
BerGenBio ASA Appoints Rune Skeie as Chief Financial Officer	18-03-05	CI
BerGenBio AS Appoints Non-Executive Directors	15-09-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer